30.09.2024, 2231 Zeichen
Aachen, Germany (OTE) - Grünenthal announced today that Jan Adams,
M.D., currently Chief
Scientific Officer (CSO) and member of the Corporate Executive Board,
will assume the role of Chief Commercial Officer (CCO) effective 1
October 2024. Prior to his role as CSO, he was Head of Strategy and
Portfolio at Grünenthal.
Jan Adams has over two decades of experience in the
pharmaceutical and healthcare industry. Since joining Grünenthal in
2017, he has been key in driving the company's transformational
journey. Under his leadership, Grünenthal successfully built a state-
of-the-art R&D organisation, redefined its R&D strategy, and built an
industry-leading pipeline focused on delivering innovative treatments
for acute and chronic pain. Before assuming the role of CSO, he
served as Head of Strategy and Portfolio, working at the interface
between Strategy, R&D, and Commercial. His role was instrumental in
several successful M&A projects and Grünenthal’s entry into the U.S.
market. Before joining Grünenthal, he held positions with increasing
responsibilities at Takeda, McKinsey & Company, and Novartis. Jan
Adams started his career as a resident in cardiology. He is a Medical
Doctor by training, married, and has two children.
Jan Adams succeeds Janneke van der Kamp, who will leave
Grünenthal to pursue an opportunity outside the company.
About Grünenthal
Grünenthal is a global leader in pain management and related
diseases. As a science-based, fully integrated pharmaceutical
company, we have a long track record of bringing innovative
treatments and state-of-the-art technologies to patients worldwide.
Our purpose is to change lives for the better - and innovation is our
passion. We focus all our activities and efforts on working towards
our vision of a World Free of Pain.
Grünenthal is headquartered in Aachen, Germany, and has
affiliates in 27 countries across Europe, Latin America, and the U.S.
Our products are available in approx. 100 countries. In 2023,
Grünenthal employed around 4,400 people and achieved revenues of Ꞓ1.8
billion.
More information: https://www.grunenthal.com
Follow us on:
LinkedIn: Grunenthal Group
Instagram: grunenthal
Digital press kit: http://www.ots.at/pressemappe/DE118252/aom
SportWoche Podcast #131: Legendäre Tennis-Momente Österreichs liegen bei den Erste Bank Open 2024 als SportWoche auf
Aktien auf dem Radar:S Immo, Addiko Bank, voestalpine, Austriacard Holdings AG, Warimpex, CA Immo, Verbund, Bawag, DO&CO, Porr, Andritz, Pierer Mobility, Kostad, Josef Manner & Comp. AG, Rath AG, Agrana, Amag, Erste Group, EVN, Flughafen Wien, OMV, Österreichische Post, Telekom Austria, Uniqa, VIG, Wienerberger, DAIMLER TRUCK HLD..., Allianz, Deutsche Telekom, SAP, Deutsche Bank.
Immofinanz
Die Immofinanz ist ein börsenotierter gewerblicher Immobilienkonzern, der seine Aktivitäten auf die Segmente Einzelhandel und Büro in sieben Kernmärkten in Europa (Österreich, Deutschland, Tschechien, Slowakei, Ungarn, Rumänien und Polen) fokussiert. Zum Kerngeschäft zählen die Bewirtschaftung und die Entwicklung von Immobilien.
>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner
Mehr aktuelle OTS-Meldungen HIER
Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab.
Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.
Newsletter abonnieren
Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)
per Newsletter erhalten
AT0000A3EKB3 | |
AT0000A3BQ35 | |
AT0000A3DYF7 |
Wiener Börse Party #757: ATX fester, Umsätze schwächer, RBI stark, Bitpanda und Steelcoin irgendwie als Hoffnung, Polytec Eco
Die Wiener Börse Party ist ein Podcastprojekt für Audio-CD.at von Christian Drastil Comm..Unter dem Motto „Market & Me“ berichtet Christian Drastil über das Tagesgeschehen an der Wiener Börse. Inha...
Mikael Siirilä
Here, In Absence
2024
IIKKI
Eron Rauch
Heartland
2023
Self published
Adolf Čejchan
Ústí nad Labem
1965
Severočeské krajské nakladatelství